Bridging Brain Connectomes and Clinical Reports for Early Alzheimer's Disease Diagnosis

TL;DR

This paper introduces a novel framework that aligns brain connectomes with clinical reports in a shared space, improving early Alzheimer's diagnosis by leveraging multimodal data and system-level brain network analysis.

Contribution

It proposes a cross-modal alignment method treating brain subnetworks as tokens, enabling better integration of imaging and clinical text data for early diagnosis.

Findings

Achieves state-of-the-art predictive performance on MCI diagnosis

Identifies meaningful connectome-text pairs related to Alzheimer's

Provides new insights into early disease mechanisms

Abstract

Integrating brain imaging data with clinical reports offers a valuable opportunity to leverage complementary multimodal information for more effective and timely diagnosis in practical clinical settings. This approach has gained significant attention in brain disorder research, yet a key challenge remains: how to effectively link objective imaging data with subjective text-based reports, such as doctors' notes. In this work, we propose a novel framework that aligns brain connectomes with clinical reports in a shared cross-modal latent space at both the subject and connectome levels, thereby enhancing representation learning. The key innovation of our approach is that we treat brain subnetworks as tokens of imaging data, rather than raw image patches, to align with word tokens in clinical reports. This enables a more efficient identification of system-level associations between neuroimaging findings and clinical observations, which is critical since brain disorders often manifest as network-level abnormalities rather than isolated regional alterations. We applied our method to mild cognitive impairment (MCI) using the ADNI dataset. Our approach not only achieves state-of-the-art predictive performance but also identifies clinically meaningful connectome-text pairs, offering new insights into the early mechanisms of Alzheimer's disease and supporting the development of clinically useful multimodal biomarkers.